PD-1/PD-L1 Inhibitor Combined with Chemotherapy Can Improve the Survival of Non-Small Cell Lung Cancer Patients with Brain Metastases

PD-1/PD-L1 Inhibitor Combined with Chemotherapy Can Improve the Survival of Non-Small Cell Lung Cancer Patients with Brain Metastases

Chenglong Sun,1,2,* Fei Zhou,3,* Xuefei Li,4 Chao Zhao,4 Wei Li,3 Jiayu Li,3 Anwen Xiong,3 Jia Yu,3 Guanghui Gao,3 Qi Wang,3 Fengying Wu,3 Caicun Zhou3 1Radiotherapy Department, Anhui No. 2 Provincial People’s Hospital, Hefei 230041, Anhui, People’s Republic of China; 2Medical Co...

Full description

Bibliographic Details
Main Authors: Sun C, Zhou F, Li X, Zhao C, Li W, Li J, Xiong A, Yu J, Gao G, Wang Q, Wu F, Zhou C
Format: Article
Language:English
Published: Dove Medical Press 2020-12-01
Series:OncoTargets and Therapy
Subjects:
nsclc
immune checkpoint inhibitors
brain metastases
survival
chemotherapy
anti-angiogenesis.
Online Access:https://www.dovepress.com/pd-1pd-l1-inhibitor-combined-with-chemotherapy-can-improve-the-surviva-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/pd-1pd-l1-inhibitor-combined-with-chemotherapy-can-improve-the-surviva-peer-reviewed-article-OTT

Similar Items